标题
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
作者
关键词
-
出版物
ARCHIVES OF PHARMACAL RESEARCH
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-05
DOI
10.1007/s12272-020-01301-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Coronavirus infections and immune responses
- (2020) Geng Li et al. JOURNAL OF MEDICAL VIROLOGY
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
- (2020) Jaume Alijotas-Reig et al. AUTOIMMUNITY REVIEWS
- Lymphopenia in COVID‐19: Therapeutic Opportunities
- (2020) Nazanin Fathi et al. CELL BIOLOGY INTERNATIONAL
- Angiotensin Converting Enzyme 2: A Double-Edged Sword
- (2020) Kaiming Wang et al. CIRCULATION
- COVID-19 and the Heart
- (2020) Akbarshakh Akhmerov et al. CIRCULATION RESEARCH
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
- (2020) Mehmet Soy et al. CLINICAL RHEUMATOLOGY
- COVID-19 cytokine storm: The anger of inflammation
- (2020) Mehdi Mahmudpour et al. CYTOKINE
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-6: Relevance for immunopathology of SARS-CoV-2
- (2020) E.O. Gubernatorova et al. CYTOKINE & GROWTH FACTOR REVIEWS
- COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease
- (2020) Daniela Tomasoni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
- (2020) Virgil Schijns et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Does lopinavir measure up in the treatment of Covid-19?
- (2020) Sheila A Doggrell EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pathophysiology of COVID-19: Why Children Fare Better than Adults?
- (2020) Nitin Dhochak et al. INDIAN JOURNAL OF PEDIATRICS
- Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity
- (2020) Andrea Picchianti Diamanti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 as an Acute Inflammatory Disease
- (2020) Rose H. Manjili et al. JOURNAL OF IMMUNOLOGY
- COVID‐19 and Renin‐Angiotensin system inhibition – role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?
- (2020) Aneta Aleksova et al. JOURNAL OF INTERNAL MEDICINE
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Potential of heparin and nafamostat combination therapy for COVID‐19
- (2020) Hidesaku Asakura et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
- (2020) Claire S Whyte et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Lopinavir–ritonavir in severe COVID-19
- (2020) Hannah Stower NATURE MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
- (2020) Peng-jiao An et al. PHARMACOLOGICAL RESEARCH
- Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)
- (2020) Francesca Salamanna et al. PLATELETS
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
- (2020) Mahesh V. Madhavan et al. THROMBOSIS AND HAEMOSTASIS
- Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
- (2020) Yu-chen Cao et al. Travel Medicine and Infectious Disease
- An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
- (2020) Kuldeep Dhama et al. Travel Medicine and Infectious Disease
- Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
- (2020) Juan Simon Rico-Mesa et al. Current Cardiology Reports
- Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
- (2020) Jean-Michel Sallenave et al. Frontiers in Immunology
- Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs
- (2020) Stefania Scala et al. Frontiers in Immunology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
- (2020) Mahdi Barzegar et al. Neurology-Neuroimmunology & Neuroinflammation
- COVID-19 Pandemic: Cardiovascular Complications and Future Implications
- (2020) Dhrubajyoti Bandyopadhyay et al. American Journal of Cardiovascular Drugs
- Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
- (2020) Brandon Michael Henry et al. CLINICA CHIMICA ACTA
- Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
- (2020) Vicki Osborne et al. DRUG SAFETY
- Basic immunology may lead to translational therapeutic rationale: SARS‐CoV‐2 and rheumatic diseases
- (2020) Elisa Gremese et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
- (2020) Massimo Imazio et al. HEART
- COVID 19: a clue from innate immunity
- (2020) Domenico Birra et al. IMMUNOLOGIC RESEARCH
- The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”
- (2020) Gholam Hossein Meftahi et al. INFLAMMATION RESEARCH
- Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
- (2020) Amene Saghazadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
- (2020) Alessandro Allegra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
- (2020) Bingwen Liu et al. JOURNAL OF AUTOIMMUNITY
- Antithrombotic Therapies in COVID-19 Disease: a Systematic Review
- (2020) Edward Maldonado et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- SARS-CoV-2 as a Factor to Disbalance the Renin–Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production
- (2020) Rafael Franco et al. JOURNAL OF IMMUNOLOGY
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Cytokine storm syndrome in coronavirus disease 2019: A narrative review
- (2020) Y.‐M. Gao et al. JOURNAL OF INTERNAL MEDICINE
- Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts
- (2020) Jin Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Novel therapeutic approaches for treatment of COVID-19
- (2020) Nikoo Hossein-khannazer et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Two hits to the renin‐angiotensin system may play a key role in severe COVID ‐19
- (2020) Yu‐Hsin Tseng et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
- (2020) Sebastiano Cicco et al. MEDIATORS OF INFLAMMATION
- Extrapulmonary manifestations of COVID-19
- (2020) Aakriti Gupta et al. NATURE MEDICINE
- Thromboinflammation in COVID-19 acute lung injury
- (2020) William Beau Mitchell Paediatric Respiratory Reviews
- COVID-19 and the Immune System
- (2020) J PACES et al. PHYSIOLOGICAL RESEARCH
- Use of remdesivir for patients with Covid-19: a review article
- (2020) Thomás Cavalcanti Pires de Azevedo et al. Revista da Associacao Medica Brasileira
- Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
- (2020) Wei Luo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
- (2020) Seyed MohammadReza Hashemian et al. Drug Design Development and Therapy
- Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
- (2020) Christian Foerch et al. Multiple Sclerosis and Related Disorders
- Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
- (2020) Rafael B. Polidoro et al. Frontiers in Immunology
- Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
- (2020) Marisa Market et al. Frontiers in Immunology
- Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
- (2020) Serena Colafrancesco et al. Frontiers in Immunology
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
- (2020) Pere Domingo et al. EBioMedicine
- COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon
- (2020) Giuseppe Lippi et al. Annals of Translational Medicine
- Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
- (2020) Alessandro Allegra et al. ANNALS OF HEMATOLOGY
- Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
- (2020) Nehla Banu et al. LIFE SCIENCES
- Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation
- (2020) Alireza Paniri et al. LIFE SCIENCES
- COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
- (2020) Giuseppe Magro VIRUS RESEARCH
- FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
- (2020) Sylwester Drożdżal et al. DRUG RESISTANCE UPDATES
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- (2019) I-Yin Chen et al. Frontiers in Microbiology
- Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
- (2019) Paul La Rosée et al. BLOOD
- Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
- (2019) Egor Tchesnokov et al. Viruses-Basel
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity
- (2015) Vaibhav B. Patel et al. DIABETES
- ACE2 and Ang-(1–7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response
- (2015) Yue-Hui Zhang et al. INFLAMMATION RESEARCH
- Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
- (2014) Fan Jiang et al. Nature Reviews Cardiology
- Type 2 alveolar cells are stem cells in adult lung
- (2013) Christina E. Barkauskas et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
- (2013) Vaibhav B. Patel et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- RIG-I and MDA-5 Detection of Viral RNA-dependent RNA Polymerase Activity Restricts Positive-Strand RNA Virus Replication
- (2013) Andrei Nikonov et al. PLoS Pathogens
- PAMPs and DAMPs: signal 0s that spur autophagy and immunity
- (2012) Daolin Tang et al. IMMUNOLOGICAL REVIEWS
- Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity
- (2012) M. J. Kaplan et al. JOURNAL OF IMMUNOLOGY
- Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
- (2011) Eva Kowalinski et al. CELL
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
- Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
- (2010) Tomoki Yoshikawa et al. PLoS One
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
- (2009) I. Glowacka et al. JOURNAL OF VIROLOGY
- Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo
- (2009) M. Ekholm et al. THROMBOSIS RESEARCH
- The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice
- (2008) Yumiko Imai et al. EXPERIMENTAL PHYSIOLOGY
- Modulation of TNF- -converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF- production and facilitates viral entry
- (2008) S. Haga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now